A Case of Pseudomonas stutzeri Bacteremia in a Patient with Hematologic Malignancy

Clicks: 435
ID: 51746
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 8 articles by views in flora infeksiyon hastalıkları ve klinik mikrobiyoloji dergisi

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Pseudomonas stutzeri is a gram-negative bacterium, ubiquitous in the environment, and it also causes opportunistic infections in humans. We describe a case with hematologic malignancy, peripheral T-cell lymphoma. The patient was hospitalized for antineoplastic chemotherapy. In the course of treatment, the patient acquired P. stutzeri, most probably from the hospital environment and bacteremia of P. stutzeri and then pneumonia developed. The bacteria were identified based on conventional microbiological identification techniques. Even though P. stutzeri is ubiquitous in the environment and a rare human pathogen, it should always be considered as a bacterial agent for opportunistic infections in hospitalized patients, especially immune depressed patients.
Reference Key
ozbek2010aflora Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ÖZBEK, Ahmet;AKTAŞ, Osman;UYANIK, M. Hamidullah;BİLİCİ, Dilek;YILDIRIM, Zuhal KESKİN;
Journal flora infeksiyon hastalıkları ve klinik mikrobiyoloji dergisi
Year 2010
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.